Lifecore Biomedical, Inc. De (LFCR) Change in Accured Expenses (2010 - 2025)

Lifecore Biomedical's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$3.5 million for Q2 2025.

• In Q2 2025, Change in Accured Expenses fell 159.96% year-over-year to -$3.5 million; the TTM figure through May 2025 stood at -$4.8 million (down 390.87% YoY), while the FY2025 annual figure was -$5.9 million, down 458.08% from the prior year.
• Change in Accured Expenses was -$3.5 million for Q2 2025 at Lifecore Biomedical, down from $225000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $5.8 million in Q2 2024 to a low of -$13.1 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged -$242666.7 across 5 years, with a median of $126500.0 in 2022.
• The sharpest annual moves came in 2021 and 2023: Change in Accured Expenses surged 2164.75% in 2021, then tumbled 18747.14% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at -$8.0 million in 2021, then soared by 132.59% to $2.6 million in 2022, then tumbled by 32.5% to $1.8 million in 2023, then tumbled by 172.02% to -$1.3 million in 2024, then tumbled by 177.48% to -$3.5 million in 2025.
• The last three Change in Accured Expenses figures came in at -$3.5 million (Q2 2025), $225000.0 (Q1 2025), and -$1.3 million (Q4 2024), per Business Quant data.